Exact Mass: 567.1168

Exact Mass Matches: 567.1168

Found 22 metabolites which its exact mass value is equals to given mass value 567.1168, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cefcamate

Cefcapene pivoxil

C23H29N5O8S2 (567.1457)


   

Cefcapene pivoxil

N-[2-({[(2,2-dimethylpropanoyl)oxy]methoxy}carbonyl)-3-[(C-hydroxycarbonimidoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)pent-2-enimidate

C23H29N5O8S2 (567.1457)


   

Uricase

{[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy})phosphinic acid amine

C18H26N5O14P (567.1214)


Uricase is also known as oxidase, urate or urate oxidase. Uricase can be found in soy bean, which makes uricase a potential biomarker for the consumption of this food product. The enzyme urate oxidase (UO), or uricase or factor-independent urate hydroxylase, absent in humans, catalyzes the oxidation of uric acid to 5-hydroxyisourate: Uric acid + O2 + H2O ‚Üí 5-hydroxyisourate + H2O2 5-hydroxyisourate + H2O ‚Üí allantoin + CO2 . Uricase is also known as oxidase, urate or urate oxidase. Uricase can be found in soy bean, which makes uricase a potential biomarker for the consumption of this food product. The enzyme urate oxidase (UO), or uricase or factor-independent urate hydroxylase, absent in humans, catalyzes the oxidation of uric acid to 5-hydroxyisourate: Uric acid + O2 + H2O → 5-hydroxyisourate + H2O2 5-hydroxyisourate + H2O → allantoin + CO2 .

   

6-Hydroxydelphinidin 3-(6-malonylglucoside)

6-Hydroxydelphinidin 3-(6-malonylglucoside)

C24H23O16 (567.0986)


   

Benzenesulfonamide,4-methyl-N,N-bis[2-[[(4-methylphenyl)sulfonyl]oxy]ethyl]-

Benzenesulfonamide,4-methyl-N,N-bis[2-[[(4-methylphenyl)sulfonyl]oxy]ethyl]-

C25H29NO8S3 (567.1055)


   

manganese phthalocyanine

manganese phthalocyanine

C32H16MnN8 (567.0878)


   
   

8-ETHOXY-N,N,N,N,N,N-HEXAMETHYLPYRENE-1,3,6-TRISULFONAMIDE

8-ETHOXY-N,N,N,N,N,N-HEXAMETHYLPYRENE-1,3,6-TRISULFONAMIDE

C24H29N3O7S3 (567.1168)


   

methyl 3-acetyl-2-oxo-6-phenylsulfanyl-4-[(1S,2R)-1,2,3-triacetyloxypropyl]-3a,4,7,7a-tetrahydropyrano[3,4-d][1,3]oxazole-6-carboxylate

methyl 3-acetyl-2-oxo-6-phenylsulfanyl-4-[(1S,2R)-1,2,3-triacetyloxypropyl]-3a,4,7,7a-tetrahydropyrano[3,4-d][1,3]oxazole-6-carboxylate

C25H29NO12S (567.141)


   
   

Prednisolone sodium metazoate

Prednisolone sodium metazoate

C28H32O9S.Na (567.1665)


   

Bis[1,3-bis( 2-ethenyl)-1,1,3,3-tetramethyldisiloxane]platinum

Bis[1,3-bis( 2-ethenyl)-1,1,3,3-tetramethyldisiloxane]platinum

C16H36O2PtSi4 (567.144)


   

2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid

2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid

C28H35Cl2NO5S (567.1613)


C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor

   

CO(III)-(Deuteroporphyrin IX)

CO(III)-(Deuteroporphyrin IX)

C30H28CoN4O4-2 (567.1442)


   

SN-38 O-beta-D-glucuronide

SN-38 O-beta-D-glucuronide

C28H27N2O11- (567.1615)


   

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl] hydrogen phosphate

[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl] hydrogen phosphate

C15H27N3O16P2 (567.0867)


   

uricase

Oxidase, urate

C18H26N5O14P (567.1214)


   
   

1-[2-(Benzhydryloxy)ethyl]-4-(3-iodo-4-azidophenethyl)piperazine

1-[2-(Benzhydryloxy)ethyl]-4-(3-iodo-4-azidophenethyl)piperazine

C27H30IN5O (567.1495)


   

3-{4-[(2-ethoxy-7-{[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl}-1H-benzimidazol-1-yl)methyl]biphenyl-2-yl}-5-oxo-1,2,4-oxadiazol-4-ide

3-{4-[(2-ethoxy-7-{[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl}-1H-benzimidazol-1-yl)methyl]biphenyl-2-yl}-5-oxo-1,2,4-oxadiazol-4-ide

C30H23N4O8- (567.1516)


   

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-hydroxy-1-(7-methoxy-2-oxo-2H-chromen-6-yl)-3-oxobutyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-hydroxy-1-(7-methoxy-2-oxo-2H-chromen-6-yl)-3-oxobutyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C24H29N3O11S (567.1523)


   

3-{[(2s,3s,4s,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,6,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium

3-{[(2s,3s,4s,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,6,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium

[C24H23O16]+ (567.0986)